Angiotensin converting enzyme in human synovium: Increased stromal [125I)351A binding in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 59, Issue 2, 2000, Pages 125-131

  Walsh, David Andrew ^a   Catravas, John ^b   Wharton, John ^c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; IODINE 125; N (1 CARBOXY 3 PHENYLPROPYL)LYSYLPROLINE 4 HYDROXYBENZAMIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; OSTEOARTHRITIS; PATELLA CHONDROMALACIA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM; TISSUE LEVEL;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARTHRITIS, RHEUMATOID; CARTILAGE DISEASES; DIPEPTIDES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; OSTEOARTHRITIS; PEPTIDYL-DIPEPTIDASE A; STROMAL CELLS; SYNOVIAL MEMBRANE;

EID: 0034084933     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.59.2.125     Document Type: Article

References (45)

1. 1 Kenny AJ, Stephenson SL, Turner AJ. Cell surface peptidases. In: Kenny AJ, Turner AJ, eds. Mammalian ectoenzymes. Oxford: Elsevier, 1987:169-210.
2. 2 Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993; 15:205-51.
3. 3 Walsh DA, Hu DE, Wharton J, Catravas JD, Blake DR, Fan TP. Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma. Br J Pharmacol 1997; 120:1302-11.
4. 4 Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994;26:809-20.
5. 5 Hafizi S, Wharton J, Morgan K, Allen SP, Chester AH, Catravas JD, et al. Expression of functional angiotensin-converting enzyme and AT1 receptors in cultured human cardiac fibroblasts. Circulation 1998;98:2553-9.
6. 6 Sadoshima J, Izumo S. Molecular characterization of angiotensin II induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 1993;73:413-23.
7. 7 Fisher SA, Absher M. Norepinephrine and ANG II stimulate secretion of TGF-beta by neonatal rat cardiac fibroblasts in vitro. Am J Physiol 1995;268:C910-17.
8. 8 Sun Y, Weber KT. Angiotensin-converting enzyme and wound healing in diverse tissues of the rat. J Lab Clin Med 1996;127:94-101.
9. 9 Sun Y, Cleutjens JP, Diaz-Arias AA, Weber KT. Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res 1994;28:1423-32.
10. 10 Wu LL, Yang N, Roe CJ, Cooper ME, Gilbert RE, Atkins RC, et al. Macrophage and myofibroblast proliferation in remnant kidney: role of angiotensin II. Kidney Int 1997;63:S221-5.
11. 11 Smits JF, van Krimpen C, Schoemaker RG, Cleutjens JP, Daemen MJ. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol 1992;20:772-8.
12. 12 van Krimpen C, Smits JF, Cleutjens JP, Debets JJ, Schoemaker RG, Struyker Boudier HA, et al. DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril. J Mol Cell Cardiol 1991;23:1245-53.
13. 13 Volpert OV, Ward WF, Lingen MW, Chesler L, Solt DB, Johnson MD, et al. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest 1996;98:671-9.
14. 14 Lowe JR, Dixon JS, Guthrie JA, McWhinney P. Serum and synovial fluid levels of angiotensin converting enzyme in polyarthritis. Ann Rheum Dis 1986;45:921-4.
15. 15 Veale D, Yanni G, Bresnihan B, FitzGerald O. Production of angiotensin converting enzyme by rheumatoid synovial membrane. Ann Rheum Dis 1992;51:476-80.
16. 16 Unger T, Gohlke P. Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors. Am J Cardiol 1990;65:3-101.
17. 17 Walsh DA, Mapp PI, Wharton J, Polak JM, Blake DR. Neuropeptide degrading enzymes in normal and inflamed human synovium. Am J Pathol 1993;142:1610-21.
18. 18 Mendelsohn FA. Localization of angiotensin converting enzyme in rat forebrain and other tissues by in vitro autoradiography using 1251-labelled MK351A. Clin Exp Pharmacol Physiol 1984;11:431-5.
19. 19 Correa FM, Guilhaume SS, Saavedra JM. Comparative quantification of rat brain and pituitary angiotensin-converting enzyme with autoradiographic and enzymatic methods. Brain Res 1991;545:215-22.
20. 20 Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29:1039-49.
21. 21 Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
22. 22 Fyhrquist F, Tikkanen I, Gronhagen-Riska C, Hortling L, Hichens M. Inhibitor binding assay for angiotensin-converting enzyme. Clin Chem 1984;30:696-700.
23. 23 Catt KJ, Baukal A. Prolonged retention of high specific activity by 1251-labeled angiotensin II - a consequence of 'decay catastrophe'. Biochim Biophys Acta 1973;313: 221-5.
24. 24 Howell S, Brewis IA, Hooper NM, Kenny AJ, Turner AJ. Mosaic expression of membrane peptidases by confluent cultures of Caco-2 cells. FEBS Lett 1993;317:109-12.
25. 25 Hsu SM, Raine L, Fanger H. Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29:577-80.
26. 26 Shu SY, Ju G, Fan LZ. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett 1988;85:169-71.
27. 27 Walsh DA, Wade M, Mapp PI, Blake DR. Focally regulated endothelial proliferation and cell death in human synovium. Am J Pathol 1998;152:691-702.
28. 28 Challah M, Nicoletti A, Arnal JF, Philippe M, Laboulandine I, Allegrini J, et al. Cardiac angiotensin converting enzyme overproduction indicates interstitial activation in renovascular hypertension. Cardiovasc Res 1995;30:231-9.
29. 29 Weinberg KS, Douglas WH, MacNamee DR, Lanzillo JJ, Fanburg BL. Angiotensin I-converting enzyme localization on cultured fibroblasts by immunofluorescence. In Vitro 1982;18:400-6.
30. 30 Katwa LC, Campbell SE, Tyagi SC, Lee SJ, Cicila GT, Weber KT. Cultured myofibroblasts generate angiotensin peptides de novo. J Mol Cell Cardiol 1997;29:1375-86.
31. 31 Rubin DB, Mason RJ, Dobbs LJ. Angiotensin-converting enzyme substrates hydrolyzed by fibroblasts and vascular endothelial cells. Exp Lung Res 1982;3:137-45.
32. 32 Wharton J, Morgan K, Rutherford RA, Catravas JD, Chester A, Whitehead BF, et al. Differential distribution of angiotensin AT2 receptors in the normal and failing human heart. J Pharmacol Exp Ther 1998;284:323-36.
33. 33 Metsarinne KP, Nordstrom DC, Konttinen YT, Teppo AM, Fyhrquist FY. Plasma interleukin-6 and renin substrate in reactive arthritis, rheumatoid arthritis, and systemic lupus erythematosus. Rheumatol Int 1992;12:93-6.
34. 34 Izai M, Miyazaki S, Murai R, Morioka Y, Hayashi H, Nishiura M, et al. Prorenin-renin axis in synovial fluid in patients with rheumatoid arthritis and osteoarthritis. Endocrinol Jpn 1992;39:259-67.
35. 35 Walsh DA, Suzuki T, Knock GA, Blake DR, Polak JM, Wharton J. AT1 receptor characteristics of angiotensin analogue binding in human synovium. Br J Pharmacol 1994;112:435-42.
36. 36 Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
37. 37 Walsh DA, Fan T-PD. Bradykinin as a growth factor. In: Farmer SG, ed. The kinin system. London: Academic Press, 1997:301-14.
38. 38 Fan TP, Hu DE, Guard S, Gresham GA, Watling KJ. Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists. Br J Pharmacol 1993; 110:43-9.
39. 39 Nilsson J, von Euler AM, Dalsgaard CJ. Stimulation of connective tissue cell growth by substance P and substance K. Nature 1985;315:61-3.
40. 40 Walsh DA, Salmon M, Mapp PI, Wharton J, Garrett N, Blake DR, et al. Microvascular substance P binding to normal and inflamed rat and human synovium. J Pharmacol Exp Ther 1993;267:951-60.
41. 41 Bathon JM, Manning DC, Goldman DW, Towns MC, Proud D. Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1. J Pharmacol Exp Ther 1992;260:384-92.
42. 42 Martin MF, Surrall KE, McKenna F, Dixon JS, Bird HA, Wright V. Captopril: a new treatment for rheumatoid arthritis? Lancet 1984;i:1325-8.
43. 43 Bird HA, Le Gallez P, Dixon JS, Catalano MA, Traficante A, Liauw LA, et al. A clinical and biochemical assessment of a nonthiol ACE inhibitor (pentopril; CGS-13945) in active rheumatoid arthritis. J Rheumatol 1990;17:603-8.
44. 44 Caspritz G, Alpermann HG, Schleyerbach R. Influence of the new angiotensin converting enzyme inhibitor ramipril on several models of acute inflammation and the adjuvant arthritis in the rat. Arzneimittelforschung 1986;36:1605-8.
45. 45 Subissi A, Guelfi M, Criscuoli M. Angiotensin converting enzyme inhibitors potentiate the bronchoconstriction induced by substance P in the guinea-pig. Br J Pharmacol 1990;100:502-6.